GARY GAY: Open Payments
NPI 1457301566 · CHURCHVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,262 in 79 payments from 13 companies in 2025. Trend: 2023 $1,249 · 2024 $1,569 · 2025 $1,262
Food & beverage: $1,262
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $226 |
| Corium, LLC | 11 | $185 |
| ABBVIE INC. | 16 | $161 |
| Axsome Therapeutics, Inc. | 8 | $160 |
| Alkermes, Inc. | 7 | $154 |
| Otsuka America Pharmaceutical, Inc. | 11 | $149 |
| E.R. Squibb & Sons, L.L.C. | 1 | $102 |
| Janssen Pharmaceuticals, Inc | 2 | $33 |
| Almatica Pharma LLC | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
Products named: CAPLYTA, Azstarys, VRAYLAR, Auvelity, ARISTADA, COBENFY, REXULTI, ABILIFY MAINTENA.
Industry payments across MD — which companies pay providers there.
